Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-041088

Chief Operating Officer sold 8,914 shares at $38.77 ($345,596)

From the SEC's structured data for this filing

Trades in this filing

ADAMS R MARK · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-06-14 Sale : show line 1 in the form −8,914 $38.77 $345,596 58,104 D
Open-market sales · 8,914 sh · avg $38.77 · $345,596
Loading xslF345X03/doc4.xml…